FAM168A participates in the development of chronic myeloid leukemia via BCR-ABL1/AKT1/NFκB pathway

被引:0
作者
Xiaorong Liu
Huirong Mai
Hanfang Jiang
Zhihao Xing
Dong Peng
Yuan Kong
Chunqing Zhu
Yunsheng Chen
机构
[1] Shenzhen Children’s Hospital,Clinical laboratory
[2] Shenzhen Children’s Hospital,Division of Hematology and Oncology
来源
BMC Cancer | / 19卷
关键词
Chronic myeloid leukemia; FAM168A; Cell proliferation; AKT1; BCR-ABL1;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 114 条
[1]  
Pemmaraju N(2014)Chronic myeloid leukemia in adolescents and young adults: patient characteristics, outcomes and review of the literature Acta Haematol 132 298-306
[2]  
Cortes J(2015)Chronic myeloid leukaemia Lancet 385 1447-1459
[3]  
Apperley JF(2018)Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring Am J Hematol 93 442-459
[4]  
Jabbour E(2009)CML: a model for targeted therapy Best Pract Res Clin Haematol 22 285-294
[5]  
Kantarjian H(2015)The role of observational studies in optimizing the clinical management of chronic myeloid leukemia Ther Adv Hematol 6 3-14
[6]  
Cilloni D(2012)Targeting the PI3K/AKT/mTOR signaling axis in children with hematologic malignancies Paediatr Drugs 14 299-316
[7]  
Saglio G(2011)Cloning and functional characterization of TCRP1, a novel gene mediating resistance to cisplatin in an oral squamous cell carcinoma cell line FEBS Lett 585 881-887
[8]  
Mauro MJ(2015)TCRP1 contributes to cisplatin resistance by preventing pol beta degradation in lung cancer cells Mol Cell Biochem 398 175-183
[9]  
Davis C(2012)Microarray-assisted pathway analysis identifies MT1X & NFkappaB as mediators of TCRP1-associated resistance to cisplatin in oral squamous cell carcinoma PLoS One 7 e51413-367
[10]  
Zyczynski T(2012)Purification and biochemical characterization of a novel protein-tongue cancer chemotherapy resistance-associated protein1 (TCRP1) Protein Expr Purif 82 360-113